Puma Biotechnology

• NCT07465757

  Phase 2, Recruiting, 50 people, 12 Mar 2026

• NCT06109467

  Collaborator, Phase 2, Active, not recruiting, 8 people, 31 Oct 2023

• NCT04901299

  Collaborator, Phase 2, Withdrawn, 0 people, 25 May 2021

• NCT04886531

  Collaborator, Phase 2, Recruiting, 30 people, 14 May 2021

• NCT03289039

  Collaborator, Phase 2, Terminated, 21 people, 20 Sept 2017

• NCT01953926

  Phase 2, Terminated, 582 people, 1 Oct 2013

• NCT01670877

  Collaborator, Phase 2, Completed, 56 people, 22 Aug 2012

• NCT01008150

  Collaborator, Phase 2, Completed, 141 people, 5 Nov 2009

• NCT00915018

  Phase 2, Completed, 479 people, 5 Jun 2009

• The FYI on MRI: Protocol for a randomized, parallel-group superiority trial of a multilevel decision support intervention to increase informed decision-making about screening breast MRI among high-risk black and Latina women

  Consulting or advice, 20 Aug 2026

Sources: pubmed.ncbi.nlm.nih.gov